← FDA Drug Approvals (Drugs@FDA)

NICOTINE POLACRILEX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2021-08-03

Drug application

FDA Application #
ANDA213266
Application type
Abbreviated New Drug Application (Generic)
Brand name
NICOTINE POLACRILEX
Generic name
NICOTINE POLACRILEX
Active ingredients
NICOTINE POLACRILEX
Dosage form
TROCHE/LOZENGE
Route
ORAL
Marketing status
Over-the-counter
Sponsor
AUROBINDO PHARMA
Manufacturer
Amazon.com Services LLC
First approval
2021-08-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown